Trials / Conditions / Neutropenia, Febrile

Neutropenia, Febrile

12 registered clinical trials studyying Neutropenia, Febrile — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Stopping Antibiotics After 3 Days for the Treatment of High-risk FEbrile Neutropenia NCT05926063	Universitaire Ziekenhuizen KU Leuven	Phase 4
Unknown	Investigation of the Usability of Neutrocheck Amongst Healthy Volunteers and Healthcare Professionals. NCT05852249	52 North Health Ltd	—
Withdrawn	CEFtolozane-Tazobactam for the Empiric Anti-bacterial Treatment of Neutropenic Fever in Hematology Patients NCT05061654	Hamad Medical Corporation	Phase 4
Withdrawn	Remote Monitoring of Patients at Risk of Sepsis NCT04260230	The Christie NHS Foundation Trust	N/A
Terminated	DIStinguishing ChildrEn at Low Risk of Severe infectioN in Case of Febrile Neutropenia-7: Impact Study of a Cl NCT04938206	University Hospital, Lille	N/A
Completed	Early Termination of Empirical Antibiotics in Febrile Neutropenia in Children With Cancer NCT04637464	Kjeld Schmiegelow	N/A
Completed	Host RNA Signature in Children With Cancer and Infection NCT04669418	Rigshospitalet, Denmark	—
Completed	Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever NCT04187755	Indonesia University	Phase 4
Completed	Antibiotics Management of Septic Neutropenic Patients in the Intensive Care Unit NCT03217721	University Hospital, Brest	—
Terminated	Early Stoppage Versus Continuation of Antimicrobial Therapy in Low Risk Pediatric Cancer Patients With Febrile NCT03003273	All India Institute of Medical Sciences	Phase 3
Completed	A Post Marketing Surveillance Study of Lipo-AB® (Amphotericin B) in Neutropenic Patients With Persistent Fever NCT03511820	TTY Biopharm	—
Unknown	Multicenter Prospective Registry Study of Diffuse Large B Cell Lymphoma NCT02474550	Ajou University School of Medicine	—